Low-cost, non-invasive melanoma detector wins award
questions I have from a clinical perspective: Today, we see skin lesions that look like melanoma and apply the ABCDE acronym for diagnosis:AsymmetryBorder irregularityColor (all the same or not)Diameter greater than 6 mmEvolving size, shape or color (over time)Now, based on this, we would then probably biopsy the lesion (any dermatologists lurking on HN wish to chime in?) and send to pathology to interpret.Will this method beat out the clinical diagnosis in terms of sensitivity (number of false negatives, which is what I would care more about) and specificity (number of false positives), such that we could biopsy more of the patients that we missed before? Additionally, would we see these changes earlier with this software and hardware?Cool idea, nonetheless. I'd be more than happy to set up some sort of clinical study looking at this technique though if there are enough tools out there to implement this myself.